Literature DB >> 2209133

Pulmonary alveolar proteinosis associated with Pneumocystis carinii. Ultrastructural identification in bronchoalveolar lavage in AIDS and immunocompromised non-AIDS patients.

J Tran Van Nhieu1, A M Vojtek, J F Bernaudin, E Escudier, J Fleury-Feith.   

Abstract

Pneumocystis carinii (PC) has been recognized as frequently responsible for most opportunistic pulmonary infections occurring in immunocompromised AIDS and non-AIDS patients. Moreover, these patients can be considered at risk for secondary pulmonary alveolar proteinosis. Therefore, we have investigated the occurrence of associated secondary alveolar proteinosis and PC pneumonitis in AIDS and non-AIDS immunocompromised patients. In a series of 26 bronchoalveolar lavages (BAL) in patients with PC pneumonitis (19 AIDS and seven non-AIDS patients), we observed on light microscopy, in addition to the honeycombed material, areas of an extracellular material that had a different pattern which was suggestive of that described in alveolar proteinosis. A systematic ultrastructural study of these 26 BAL fluid samples demonstrated in each of them an accumulation of phospholipid surfactantlike extracellular material mixed or not with the PC cysts. In nine cases, the observation of lipoproteinaceous material on light microscopy and abundant phospholipid material with myelinlike and myelin tubular laminated structures on electron microscopy was highly suggestive of an associated pulmonary alveolar proteinosis (PAP). Such an accumulation of extracellular material was not observed in the 11 BAL fluid samples collected in immunocompromised patients (seven AIDS and four non-AIDS patients) without PC pneumonitis. These findings demonstrated a particular frequency of associated PAP with PC pneumonitis. These results raise important questions concerning (1) the consequence of such an alveolar accumulation of lipoproteinaceous material on the clinical status and prognosis of the pneumonitis, and (2) the mechanisms responsible for this accumulation.

Entities:  

Mesh:

Year:  1990        PMID: 2209133     DOI: 10.1378/chest.98.4.801

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  17 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

Review 2.  The molecular basis of pulmonary alveolar proteinosis.

Authors:  Brenna Carey; Bruce C Trapnell
Journal:  Clin Immunol       Date:  2010-03-25       Impact factor: 3.969

Review 3.  Secondary alveolar proteinosis in cancer patients.

Authors:  S Ladeb; J Fleury-Feith; E Escudier; J Tran Van Nhieu; J F Bernaudin; C Cordonnier
Journal:  Support Care Cancer       Date:  1996-11       Impact factor: 3.603

4.  Induction of fibrinogen expression in the lung epithelium during Pneumocystis carinii pneumonia.

Authors:  P J Simpson-Haidaris; M A Courtney; T W Wright; R Goss; A Harmsen; F Gigliotti
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  Pulmonary alveolar proteinosis. A spontaneous and inducible disease in immunodeficient germ-free mice.

Authors:  T Warner; E Balish
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

6.  120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A.

Authors:  P E Zimmerman; D R Voelker; F X McCormack; J R Paulsrud; W J Martin
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

7.  Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages.

Authors:  D M O'Riordan; J E Standing; K Y Kwon; D Chang; E C Crouch; A H Limper
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

8.  Effects of decreased calmodulin protein on the survival mechanisms of alveolar macrophages during Pneumocystis pneumonia.

Authors:  Mark E Lasbury; Pamela J Durant; Chung-Ping Liao; Chao-Hung Lee
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

Review 9.  Update on Diffuse Lung Disease in Children.

Authors:  Timothy J Vece; Lisa R Young
Journal:  Chest       Date:  2016-01-12       Impact factor: 9.410

10.  SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance.

Authors:  David N Douda; Nicole Farmakovski; Sharon Dell; Hartmut Grasemann; Nades Palaniyar
Journal:  Orphanet J Rare Dis       Date:  2009-12-23       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.